Martha Neagu Aristide

Company: Abbvie

Job title: Senior Medical Director

Seminars:

ABBV-400 – A c-Met Targeting ADC With Activity in CRC & MET Amplified Tumours 5:30 pm

Exploring the background of ABBV-400 Analysing the safety profile of ABBV-400 and forward planning for tox-related concerns Highlighting the efficacy of this promising ADC and how it can provide hope for the treatment of MET amplified tumours Discussing future directions and considerations for optimizationRead more

day: Conference Day One